Latest United Kingdom News

Commonwealth Bank of Australia has updated its 2026 interim dividend details, confirming a fully franked payout of AUD 2.35 per share and setting the Dividend Reinvestment Plan price at AUD 174.47 with no discount.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Telix Pharmaceuticals has announced that Part 1 of its ProstACT Phase 3 trial for TLX591-Tx met its primary safety and dosimetry objectives, with no new safety concerns. The study’s success supports ongoing global enrolment in Part 2 and regulatory engagement in the US.

Suncorp Group Limited has updated the dividend reinvestment price for its fully franked ordinary dividend relating to the six months ending December 2025. The dividend of 17 cents per share will be paid on 31 March 2026, with flexible currency options for shareholders.

Ansell Limited has updated its FY26 interim dividend details, confirming a USD 0.266 per share payout and setting the Dividend Reinvestment Plan price at USD 22.24 per share. The dividend will be paid in US dollars with an Australian dollar equivalent of AUD 0.3768 per share.

Commonwealth Bank of Australia has updated its interim dividend details, confirming a fully franked payout of AUD 2.35 per share with multi-currency payment options and a Dividend Reinvestment Plan participation of 13.5%.

Memphasys Limited has advanced its Felix™ System commercial rollout with key regulatory approvals and new international contracts, while trimming operating costs and narrowing losses in the first half of FY2026.

Wesfarmers has updated its dividend details, confirming a fully franked ordinary dividend of AUD 1.02 per share for the half-year ending December 2025, with payment scheduled for March 31, 2026. Shareholders can choose to receive payments in AUD, NZD, or GBP, reflecting the company’s international shareholder base.

Omni Bridgeway Limited reported a striking half-year performance with a 357% jump in net profit and a robust pipeline of legal finance investments. The company’s transformation into a capital-light fund manager is gaining momentum amid favourable regulatory shifts.

Suncorp Group Limited has updated its dividend distribution details, confirming a fully franked ordinary dividend of AUD 0.17 per share payable in March 2026, with tailored currency payment options for shareholders.

Biome Australia Limited has reported a robust half-year performance, with revenues climbing nearly 40% and net profit more than doubling, driven by strong product momentum and strategic investments.

Alcidion has secured regulatory approval for its AI-powered clinical tool in Australia and the UK, paving the way for commercial rollout in its largest markets. This milestone strengthens its position in healthcare technology and opens new sales avenues.